Skip to main content
PLOS One logoLink to PLOS One
. 2020 Dec 17;15(12):e0243441. doi: 10.1371/journal.pone.0243441

Multiscale based nonlinear dynamics analysis of heart rate variability signals

Syed Zaki Hassan Kazmi 1, Nazneen Habib 2, Rabia Riaz 1, Sanam Shahla Rizvi 3, Syed Ali Abbas 1, Tae-Sun Chung 4,*
Editor: Elena G Tolkacheva5
PMCID: PMC7746153  PMID: 33332361

Abstract

Acceleration change index (ACI) is a fast and easy to understand heart rate variability (HRV) analysis approach used for assessing cardiac autonomic control of the nervous systems. The cardiac autonomic control of the nervous system is an example of highly integrated systems operating at multiple time scales. Traditional single scale based ACI did not take into account multiple time scales and has limited capability to classify normal and pathological subjects. In this study, a novel approach multiscale ACI (MACI) is proposed by incorporating multiple time scales for improving the classification ability of ACI. We evaluated the performance of MACI for classifying, normal sinus rhythm (NSR), congestive heart failure (CHF) and atrial fibrillation subjects. The findings reveal that MACI provided better classification between healthy and pathological subjects compared to ACI. We also compared MACI with other scale-based techniques such as multiscale entropy, multiscale permutation entropy (MPE), multiscale normalized corrected Shannon entropy (MNCSE) and multiscale permutation entropy (IMPE). The preliminary results show that MACI values are more stable and reliable than IMPE and MNCSE. The results show that MACI based features lead to higher classification accuracy.

Introduction

Biological signals are output of complex integrated subsystem, whose behaviour evolves with time [1]. Due to the interaction of numerous subsystems, the biological systems have the capability to evolve and adjust their self in a dynamic environment. The hierarchy of structural sub- systems and coupling between them depict the biological systems operate across multiple spatial and temporal scales [24]. Hence, information extracted at single time scale may not be dynamically correct. Multiscale Entropy (MSE) was proposed by Costa et al. [2], for extracting information from biological signals and validated that biological signals provide dynamically incorrect information at single time scale. Since then, MSE has been applied in numerous fields including biomedical signal processing [2, 3, 5, 6], electro-seismic time series data [7] and financial time series [8]. Various variants of original MSE have been proposed by either changing the coarse graining procedure or by using different entropy estimate to quantify the dynamical information and to address its drawbacks [6, 912].

In MSE, initially a coarse-grained procedure is applied on the original time series, according to the scale factor τ. On scale 1, the resultant coarse-grained time series is the original time series itself. At scale two, the average of ith and (i+1)th value in the time series is taken to form the coarse-grained time series and its size is calculated by dividing the original time series with τ. Then, Sample Entropy (SE) of coarse-grained time series is computed and plotted in contrast to scale factor.

MSE required long size time series and the size of error bars increases in small time series, because size of the coarse-grained time series heavily depends on the scale factor. Original author of MSE used 20000 data points and calculated entropy for 20 scales. Similarly, MSE is also affected by non-stationarity, because of fixed size of similarity criterion (r). MSE was successfully applied for healthy (NSR) and diseased (CHF) subjects. Diseased subject had lower complexity as compared to healthy subjects [2, 3].

MSE uses sample entropy on the coarse-graining time series, whereas Multiscale Permutation Entropy (MPE) uses concept of Permutation Entropy (PE) on multiple scales of coarse-grained time series. PE is advantageous in the presence of dynamical noise, so it can be successfully used to characterize the healthy and diseased subjects [13]. Gaussian white noise was used to compute the MPE. The results of the computation were compared with Multiscale entropy (MSE). It was found that both SE and PE decreased monotonically as the scale factor increases [13]. Healthy (NSR) and diseased (CHF) subjects were compared and it was found that healthy subjects are more irregular on large time scales as compared to the original time series.

In MSE, increase in the scale factor results in a decreased coarse-grained time series, and the variance of the entropy’s coarse-grained series is increased, which is estimated by SE. The variance would become high at large scale of estimated entropy values, which results in a decreased reliability, making time series difficult to distinguish. Composite Multiscale entropy (CMSE) was proposed to reduce the variance at large scales of estimated entropy, which showed good performance for short time series [10, 11]. Both 1/f noise and while noise data was used for computation of CMSE and MSE and while comparing the results of both estimates, it was found that CMSE gave reliable estimation of entropy than MSE.

Recently sign time series analysis methods were applied for quantifying the information carried by biological signals [14]. Ashkenazy et al. (2000) in their scaling analysis of RR time series, used the sign series (sign of difference of the time series) as an intermediary time series [14]. They derived two sub series: magnitude mi = |ΔRRi | and sign series si = sign(ΔRRi) from the original time series. They obtained scaling exponent by using detrended fluctuation analysis (DFA) [15] on sign series. To quantify the dynamics information from inter beat interval time series data (healthy and pathological) Garcia-Gonzalez proposed Acceleration change index (ACI) [16]. ACI is closely related to the time series autocorrelation function. The study revealed that ACI was lower in control groups compared to pathological subjects ACI is robust in case of dynamical and observational noise, however, its classification ability is modest. Thus, using ACI for quantifying the dynamical information from coarse grained time series generated using multiscale coarse graining procedure can be an important endeavour for distinguishing healthy and pathological. In this study, we propose multiscale ACI (MACI) to investigate the dynamical fluctuations of interbeat interval time series for assessing cardiac autonomic control at multiple time scale improve classification ability of ACI for distinguishing healthy and pathological Subjects.

Materials and methods

The scale-based acceleration change index named as multiscale acceleration change index (MACI) is the modified form of acceleration change index (ACI). ACI was proposed Garcia-Gonzalez et al [16] for characterizing the dynamics of HRV signals [13], which is closely related to autocorrelation function of a given signal. Garcia-Gonzalez et al [16] described in detail the mathematical background relation between autocorrelation function and ACI of the time series. The results reported by Garcia-Gonzalez et al [16] aver that ACI was lower in control groups compared to post-infarct (PI) groups. On comparing with standard linear HRV measures such Mean RR, standard deviation of normal to normal RR-intervals (SDNN), root mean square of the successive differences (RMSSD) and ratio of low frequency to high frequency (LF/HF) with linear ACI was only index that provided significant no other indices except ACI provide significant difference between the groups [16].

The cardiac autonomic control maintained by balancing action of sympathetic and parasympathetic branches of the autonomic nervous system comprises of feedback controlling mechanism operating at multiple time scales. Traditional ACI did not consider multiple time scales and can have limited capability to classify healthy and different pathological groups. To address this issue, a novel approach MACI is proposed by incorporating multiple time scales to extract dynamical information encoded by the HRV signals about healthy and pathological systems.

Acceleration change index (ACI)

To calculate ACI of time series data following procedure was adopted.

Step 1: Given the RR-interval time series. The differentiated RR-interval (DRR) (DRR) time series is obtained as:

DRR(n)=RR(n+1)RR(n),n[N1]

Where N is the total number of RR-intervals and RR(n) is the RR interval from beat n to beat n+1, and.

Step 2: Sign of DRR (SDRR) is obtained by quantizing DRR series in ‘0’ and ‘1’. SDRR is ‘0’ if DRR<0 and ‘1’ if DRR> = 0.

Step 3: Starting from n = 1 to n = N—1, we generate the sign change (SC) series as

SC(j)=n
ifSDRR(n)SDRR(n1),j[1,M+1]

Where M + 1 is the number of sign changes. SC(j) = n implies that RR(n) is the jth local maximum or minimum of the tachogram with respects to threshold T.

Step 4: Sign change series is differentiated to obtain DSC, which is the distance (in beats) between successive changes of sign of the DRR time series:

DSC(j)=SC(j+1)SC(j)

The Acceleration change index (ACI) is defined as:

ACI=k/M

Where k is the number of times DSC time series equal 1 and M is the total number of samples of DSC time series.

Multiscale acceleration change index (MACI)

To compute the corresponding ACI over a sequence of scale factors MACI is used. The coarse-grained time series, y(τ), can be constructed at a scale factor of τ, for a one-dimensional time series, x = {x1,x2,…., xN}, according to the following equation:

yjτ=1τi=(j1)τ+1jτxi,1jNτ

The coarse-grained time series is divided into non-overlapping windows of length τ, and the data points inside each window are averaged as shown in Fig 1 [17, 18]. To find MACI value, we then define the ACI measurement of each coarse-grained time series.

Fig 1. Schematic illustration of the coarse grained procedure.

Fig 1

MACI(x,τ)=ACI(y(τ))

The MACI for each scale is computed by applying ACI on coarse-grained time series, y(τ)

The length of time series data is important for most of the nonlinear measurements. In MACI the length of time series after coarse-grained procedure is equal to the length of original time series divided by scale factor (τ). As the length of coarse-grained time series is reduced the variance of ACI measurements grows. Flow chart of MACI algorithm is presented in Fig 2.

Fig 2. Flow chart of the MACI algorithm.

Fig 2

Statistical analysis and evaluation metrics

The analysis of variance (ANOVA) was used to analyse the differences among groups means and their concomitant measures for three or more groups. The one-way ANOVA is an omnibus approach, significant F statistic indicates that group means are statistically different, if any one of the groups is significantly different, but does not make paired comparison. The Bonferroni post-hoc test was used for multiple comparisons among the groups. The degree of separation among groups was quantified by using Area under receiver operator characteristic Curve (AUC) values (Mcneil & Hanley, 1984). The AUC is generally distinguished index for quantifying the level of separation between the groups. The AUC values show perfect separation of two groups at maximum value that is 1 and 0.5 value of AUC correspond to separation of groups by pure chance.

Data sets

In this study we used data sets of normal sinus rhythm, congestive heart failure and atrial fibrillation. The details of these data sets are illustrated in Table 1.

Table 1. Data sets (R-wave to R-wave interval) used in the study.

Number of subjects Data Sets Source of Data
72 Normal sinus rhythm (NSR) The 72 normal sinus rhythm subjects in which 35 male and 37 females were taken from publicly available databases of physio net. The age of the subjects was between 20 to 78 years. The 24 subjects taken from MIT-BIH NSR database comprised of 18 hours ECG recordings. Rest of 48 subjects taken from NSR RR interval database comprising of 54 beat annotation files of long-term ECG recording [19, 20].
44 Congestive heart failure (CHF) The 44 congestive heart failure subjects in which 29 male and 15 females were taken from physio net (publicly available database). The 15 sever CHF subjects were taken from BIDMC CHF database. Rest of 29 subjects taken from CHF RR interval database comprising of 29 beat annotation files for long term ECG recordings [20].
24 Atrial fibrillation (AF) The 24 atrial fibrillation subjects were taken from physio net a publicly available database. All-time series AF data sets comprise of 10 hours single recording [20].

Results

The performance of MACI was evaluated for distinguishing healthy and pathological groups at multiple time scale using coarse graining procedure. The mean of the time series was used as criterion for transforming original time series into coarse grained time series at multiple time scales. The results of MACI were compared with original ACI algorithm (MACI at temporal scale 1) for distinguishing healthy and pathological groups.

In the Table 2, results of ANOVA for comparing NSR, CHF and AF subjects using ACI and MACI(Mean) indices is presented. In the table columns are labelled Sum of Squares (between and within the groups), df (degrees of freedom between and within the groups), Mean Square (between and within the groups), F measure and Sig. The only column labelled Sig., representing significance level of ANOVA, is important from researcher’s perspective for interpretation results and all other columns are used mainly for intermediary computational tasks. If the value (s) of Sig. in this column is (are) less than the critical value set by the researcher (say, 0.05), then the outcome will result in significant effects, while value(s) greater 0.05 value will depict that effects are not statistically significant. The statistically significant results demonstrate that differences between groups are not by chance or sampling error. The F-measure is basically the ratio of variability between groups compared to the variability within the groups determining whether sample means are within sampling variability of each other.

Table 2. ANOVA table of ACI (MACI at temporal scale 1) and MACI (mean) indices for distinguishing NSR, CHF and AF subject.

Time Scale Mean ± STD Sum of Squares Df Mean Square F Sig.
NSR CHF AF B/W Group Within Group B/W Group Within Group B/W Group Within Group
1 0.57±0.09 0.61±0.08 0.54±0.11 0.105 1.086 2 137 0.052 0.008 6.616 1.81×10−3
2 0.52±0.09 0.63±0.07 0.64±0.10 0.500 1.039 2 137 0.250 0.008 32.96 2.06×10−12
3 0.41±0.07 0.57±0.08 0.58±0.09 0.936 0.872 2 137 0.468 0.006 73.56 1.99×10−22
4 0.42±0.06 0.53±0.09 0.56±0.07 0.561 0.738 2 137 0.280 0.005 52.05 1.53×10−17
5 0.47±0.06 0.52±0.09 0.56±0.06 0.181 0.701 2 137 0.090 0.005 17.66 1.50×10−7
6 0.50±0.06 0.50±0.07 0.57±0.05 0.091 0.541 2 137 0.046 0.004 11.57 2.27×10−5
7 0.52±0.05 0.50±0.07 0.57±0.05 0.061 0.480 2 137 0.030 0.004 8.644 2.91×10−4
8 0.53±0.04 0.50±0.07 0.56±0.05 0.057 0.404 2 137 0.029 0.003 9.743 1.10×10−4
9 0.53±0.04 0.50±0.06 0.56±0.05 0.060 0.342 2 137 0.030 0.002 11.93 1.67×10−5
10 0.53±0.04 0.49±0.06 0.57±0.06 0.095 0.339 2 137 0.047 0.002 19.14 4.67×10−8

The larger F–measure depicts that the probability of real effects is statistically significant. When the effects are statistically significant, the means needs to be examined to determine the nature of the effects using Post-hoc test. The results presented in the Table 2, indicated that the value of ACI (MACI at temporal scale 1) for normal subjects is lower than CHF subject and higher than AF subjects resulting in incorrect dynamical information. When scale is increased, the MACI value for normal subjects became smaller than both CHF and AF subjects, showing that ACI is higher for both disease groups. The results also indicated that F-measure started to increase when temporal scales were increased. The increase in F-measure with temporal scales depicted that probability of real effects in separating healthy and pathological has increased. Since the results are statistically significant, the means needs to be examined to determine the nature of the effects using Post-hoc test.

In Table 3, Bonferroni post-hoc test is carried out for multiple comparisons of NSR and CHF, AF (disease) subjects. The results indicated that maximum separation between NSR and CHF subjects was obtained at temporal scale τ = 3, (mean difference -0.1586 and p-value = 1.58×10−18). Similarly, the maximum separation between NSR and AF subjects was obtained at temporal scale τ = 3 (mean difference -0.1721, sig. = 2.07×10−15) and CHF and AF subjects was obtained at temporal scale τ = 10 (mean difference -0.0773, p-value = 2.73×10−8).

Table 3. Comparisons of NSR, CHF and AF subjects on the basis of ACI (MACI at temporal scale 1) and MACI (mean).

Time Scale Mean Difference of the groups P-Value
NSR VS CHF NSR VS AF CHF VS AF NSR VS CHF NSR VS AF CHF VS AF
1 -0.0476 0.0284 0.0760 1.78×10−2 5.34×10−1 2.97×10−3
2 -0.1145 -0.1278 -0.0133 6.07×10−10 1.62×10−8 1
3 -0.1586 -0.1721 -0.0135 1.58×10−18 2.07×10−15 1
4 -0.1141 -0.1448 -0.0306 6.93×10−13 1.78×10−13 3.06×10−1
5 -0.0538 -0.0919 -0.0381 3.99×10−4 6.79×10−7 1.13×10−1
6 -0.0028 -0.0688 -0.0660 1 2.38×10−5 1.82×10−4
7 0.0202 -0.0422 -0.0624 2.30×10−1 8.94×10−3 1.71×10−4
8 0.0309 -0.0280 -0.0589 1.04×10−2 9.14×10−2 1.07×10−4
9 0.0288 -0.0321 -0.0610 9.19×10−3 2.16×10−2 1.19×10−5
10 0.0347 -0.0426 -0.0773 1.12×10−3 1.19×10−3 2.73×10−8

It is evident from Table 2, for temporal scales 2 and 3, mean MACI values of CHF and AF pathological groups are almost same, however, interbeat interval time series of both pathological groups are outcome of different cardiac dynamics. Similarly, at temporal scales 6 and 7, mean MACI of NSR and CHF subjects almost same. Thus, to differentiate the time series of dynamical processes, both specific values of MACI and the dependence of MACI values at temporal scales needs to take into consideration.

In Fig 3, comparison ACI and MACI (optimal scale) for separation of NSR vs CHF, NSR Vs AF and NSR Vs CHF are shown. It is evident from the figure, ACI was modest in separating these groups, however, MACI at optimal threshold values revealed significantly high separation between the different groups. MACI showed highest separation between NSR and both pathological groups (CHF and AF) at optimal scale 3 and highest separation between two pathological groups CHF Vs AF was obtained at temporal scale 10. The findings aver that small temporal scale can distinguish healthy and pathological groups due to considerable difference in the dynamical information provided by HRV signals, however, for separating path.

Fig 3.

Fig 3

Comparison of ACI and MACI (at optimal scale) for classification of (a) NSR Vs CHF, (b) NSR Vs AF and (c) CHF Vs AF subjects.

In Fig 4, performance evaluation metrics sensitivity, specificity, positive predictive value (PPV), false discovery rate (FDR), negative predictive value (NPV), false omission rate (FOR) and total accuracy are shown for classification of NSR vs CHF, NSR Vs AF and NSR Vs CHF subjects using the Multilayer perceptron and 10-fold cross validation strategy. It is evident from figure all the evaluation metrics revealed higher classification ability of MACI at optimal scales for classification of different groups.

Fig 4.

Fig 4

Performance evaluation of ACI and MACI (at optimal scale value) for classification of (a) NSR Vs CHF, (b) NSR Vs AF and (c) CHF Vs AF subjects.

In Fig 5, the area under ROC curve (AUC) is shown for assessing the degree of separation between NSR Vs CHF, NSR Vs AF and CHF and AF subjects by plotting “1-specificity” against “sensitivity”. AUC is a well-established index of diagnostic accuracy. The AUC = 0.5 shows picking a class by a pure chance and AUC = 1 reveals perfect separation between two classes. Higher values of AUC for MACI reveal higher classification ability of this index at optimal time scales compared ACI.

Fig 5.

Fig 5

AUC for assessing degree of separation using ACI and MACI at optimal scale (a) NSR Vs CHF (b) NSR Vs AF and (c) CHF Vs AF subjects.

In Fig 6, results of MACI for different signal lengths to classify NSR and CHF subjects are illustrated. The findings show that optimal separation between NSR and CHF was found at time scale 3 for signal length >1000, and for signal lengths < = 1000, time scale 2 provided maximum separation followed by the time scale 3. The results demonstrate that almost for all the signal lengths optimal time scale 3 is consistent for classifying NSR and CHF subjects.

Fig 6. Variations in the MACI values at different time scales with signal length.

Fig 6

In Fig 7, switching averaging brackets to right to investigate that coarse graining procedure is stable or not. We investigated the effect by switching the averaging brackets 1 to 4 steps to right. WE found overlap of MACI values at switching brackets 1 to 4 steps. It is inferred out for small switching brackets coarse graining procedure is stable and does not affect the MACI at different threshold values.

Fig 7. Switching of averaging brackets to the right.

Fig 7

Furthermore, the performance of MACI was evaluated by comparing it with other nonlinear multiscale based techniques (Improved Multiscale Permutation Entropy (IMPE) [21] and Multiscale Normalized Corrected Shannon Entropy (MNCSE) [22]). The effectiveness of the proposed approach is demonstrated using interbeat interval signals from healthy and pathological subjects. The only column labelled Sig., representing significance level and if the value (s) of Sig. in this column is (are) less than the critical value set by the researcher (say, 0.05), then the outcome will result in significant effects, while value(s) greater 0.05 value will depict that effects are not statistically significant. The statistically significant results demonstrate that differences between groups are not by chance or sampling error.

In Table 4, corresponding p-values of MACI, IMPE and MNCSE for healthy and pathological subjects are presented at temporal scales 1 to 10. Scales based measure MACI, IMPE and MNCSE were able to discriminate healthy from pathological group more significantly at a wide range of scales. The maximum separation between healthy and pathological subjects was obtained at temporal scale 3(p-value = 1.58×10−18) for MACI, temporal scale 7(p-value = 1.00×10−2) for IMPE and temporal scale 4(p-value = 2.72×10−6) for MNCSE. It is evident that the differences between MACI, IMPE and MNCSE estimates were smaller at scale 1, as compared to multiple time scale. The MACI provided was more robust in distinguishing healthy and pathological subjects.

Table 4. Corresponding p-values comparison of MACI, IMPE and MNCSE at temporal scales 1 to 10 for quantifying the dynamics of healthy (NSR) and pathological (CHF) subjects.

Time Scale Sig.
MACI IMPE MNCSE
1 1.78×10−2 5.10×10−1 6.62×10−1
2 6.07×10−10 3.46×10−1 2.18×10−3
3 1.58×10−18 8.51×10−1 6.26×10−5
4 6.93×10−13 2.86×10−1 2.72×10−6
5 3.99×10−4 1.16×10−1 2.72×10−6
6 1 1.70×10−2 2.94×10−6
7 2.30×10−1 1.00×10−2 8.98×10−6
8 1.04×10−2 7.60×10−3 1.12×10−5
9 9.19×10−3 1.10×10−2 2.11×10−5
10 1.12×10−3 1.10×10−2 5.13×10−5

Discussion

The cardiac autonomic control is regulated by the interacting mechanism of sympathetic and parasympathetic branches of autonomic nervous system (ANS) and its ability to adapt and function in a dynamic environment. Higher adaptive of capability of ANS to regulate cardiac autonomic control reveals HRV signals of heathy subject reflect higher complexity [2] and decreased ACI [13, 16]. Aging and disease reduce the adaptive capability of the ANS and degrade cardiac autonomic, which results in loss of complexity and increase in ACI. The recent research evidences [2, 21, 22] reveal that studying dynamics of these signals at traditional single scale provides misleading information. In this study, we analysed the dynamics of healthy and pathological using a novel index MACI to investigative robustness of incorporation of multiple time to quantify dynamics of HRV signals extracted from ECG recording of NSR, CHF and AF subjects.

It is evident from Table 2 and Fig 3, ACI (TACI at τ = 1) showed dynamically incorrect results for AF subjects (0.54±0.11) compared to NSR (0.57±0.09). Incorporating multiple time scales resulted in lower ACI for NSR subjects compared to both AF and CHF subjects revealing that dynamical route of disease is associated with increase of ACI. Basically, ACI increases when local maxima are immediately followed by local minima and vice versa [13, 16]. In healthy subjects controlling mechanism of ANS regulates heartbeat and controls the immediate alternations of local maxima and local minima, which results is decrease in ACI in healthy subjects. However, in case pathological subjects due to loss of adaptive capability, controlling mechanism of ANS fails to regulate heartbeat, which causes immediate alternations in heartbeat, which results in the increase of ACI. Thus, increase in ACI is associated with the dynamics route of disease and decrease in ACI is associated with healthy dynamics.

We used standard multiscaling procedure proposed by Costa et al [2] for generating coarse grained time series. We observed significantly lower MACI for NSR subjects compared to CHF and AF subjects at time scales 2 to 5 and at time scales 2 to 10 respectively. The significant difference between CHF and AF was observed at times scales 4 to 10. The highest separation between NSR vs CHF and NSR vs AF was obtained at time scale 3, whereas for NSR vs AF subjects, maximum separation was obtained at time scale 10. Thus, we merely iterated time scale iterated time scale values from 1 to 10 to characterize the heart rate dynamics of healthy and pathological subjects. The findings aver that along with specific MACI values, we need to consider their dependence on time scale for better characterization of HRV signals of healthy and pathological subjects.

The present study investigated dynamics of heart rate variability signals to assess cardiac autonomic control of nervous system. Thus, we need not to consider the morphology of the ECG signal, instead, we extracted RR-intervals (interbeat intervals) from the ECG signal and used MACI, which is an extension ACI for assessing dynamical fluctuations of healthy and different pathological subjects. The sign change in the time series occurs when an increasing interval immediately is followed by the decreasing interval and vice versa. Thus, sign information is enough for investigating the dynamical fluctuations of the heart, which assist the clinicians to asses cardiac autonomic control and its variations occurring due to aging and disease.

We also investigated the variations in MACI values for different signal lengths to classify NSR and CHF subjects. The findings show that optimal separation between NSR and CHF was found at time scale 3 for signal length >1000, and for signal lengths < = 1000, time scale 2 provided maximum separation followed by the time scale 3. The results demonstrate that almost for all the signal lengths optimal time scale 3 is consistent for classifying NSR and CHF subjects. The optimal value of time scale revealing highest separation between NSR vs CHF and NSR vs AF was 3, whereas for NSR vs AF subjects optimal scale was 10. Thus, optimal scale is different for separating NSR subject from pathological (NSR Vs CHF of NSR Vs AF) subjects compared to optimal scale for separating two pathological groups (CHF Vs AF). The findings aver that along with specific MACI values, we need to consider their dependence on time scale for better characterization of HRV signals of healthy and pathological subjects.

Conclusion

In this study, we proposed multiscale acceleration change (MACI) to analyse the dynamics of HRV signals accurately and improve classification ability of ACI. to classify healthy and pathological subjects. The preliminary results aver that MACI provided dynamically more accurate information compared ACI and outperformed ACI at wide range of temporal scales in classifying healthy and pathological subjects. We also compare MACI with IMPE and MNCSE for assessing the robustness the proposed index. The performance parameters clearly demonstrated that proposed MACI provided better separation between these groups than traditional ACI, IMPE and MNCSE measures. The contributions of this research are twofold. The empirical results show that classification ability of ACI has increased by incorporation of multiple time scales and this index more effective in analysing dynamics HRV signals accurately. The present investigated performance of MACI for classifying only HRV signals of healthy and pathological subjects. Further studies are suggested to evaluate the robustness of MACI for analysing other biological signals such as electroencephalographic recording and stride interval time series of healthy and neurodegenerative disease subjects.

Data Availability

The data used in the study is publicly available at https://physionet.org/about/database/. We have used following specific datasets. • MIT-BIH Normal Sinus Rhythm Database. https://physionet.org/content/nsrdb/1.0.0/ • Normal Sinus Rhythm RR Interval Database. https://physionet.org/content/nsr2db/1.0.0/ • BIDMC Congestive Heart Failure Database. https://physionet.org/content/chfdb/1.0.0/ • Congestive Heart Failure RR Interval Database. https://physionet.org/content/chf2db/1.0.0/ • MIT-BIH Atrial Fibrillation Database. https://physionet.org/content/afdb/1.0.0/.

Funding Statement

Basic Science Research provided support for this study through the National Research Foundation of Korea (NRF) funded by the Ministry of Education in the form of a grant awarded to TSC (2019R1F1A1058548). This funder played a role in study design, decision to publish, and preparation of the manuscript, but did not play a role in data collection or analysis. Raptor Interactive (Pty) Ltd. provided support in the form of a salary for SSR. The specific roles of this author are articulated in the ‘author contributions’ section. This funder played a major role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Massaro S., & Pecchia L. (2019). Heart rate variability (HRV) analysis: A methodology for organizational neuroscience. Organizational Research Methods, 22(1), 354–393. [Google Scholar]
  • 2.Costa M., Goldberger A. L. & Peng C. K. (2002). Multiscale entropy to distinguish physiologic and synthetic RR time series. Computers in Cardiology 29: 137–140. [PubMed] [Google Scholar]
  • 3.Salmoirago-Blotcher E., Hovey K. M., Andrews C. A., Allison M., Brunner R. L., Denburg N. L., et al. (2019). Psychological traits, heart rate variability, and risk of coronary heart disease in healthy aging women-the Women's Health Initiative. Psychosomatic medicine. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kazmi S. Z. H., Zhang H., Aziz W., Monfredi O., Abbas S. A., Shah S. A., et al. (2016). Inverse correlation between heart rate variability and heart rate demonstrated by linear and nonlinear analysis. PloS one, 11(6), e0157557 10.1371/journal.pone.0157557 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.de Geus E. J., Gianaros P. J., Brindle R. C., Jennings J. R., & Berntson G. G. (2019). Should heart rate variability be “corrected” for heart rate? Biological, quantitative, and interpretive considerations. Psychophysiology, 56(2), e13287 10.1111/psyp.13287 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Nikulin V. V., & Brismar T. (2004). Comment on “Multiscale entropy analysis of complex physiologic time series”. Physical review letters, 92(8), 089803 10.1103/PhysRevLett.92.089803 [DOI] [PubMed] [Google Scholar]
  • 7.Guzman L., Ramírez-Rojas A., & Angulo-Brown F. (2008). Multiscale entropy analysis of electroseismic time series. Natural Hazards and Earth System Sciences, 8(4), 855–860. [Google Scholar]
  • 8.Niu H., & Wang J. (2015). Quantifying complexity of financial short-term time series by composite multiscale entropy measure. Communications in Nonlinear Science and Numerical Simulation, 22(1), 375–382. [Google Scholar]
  • 9.Valencia J. F., Porta A., Vallverdu M., Claria F., Baranowski R., Orlowska-Baranowska E., et al. (2009). Refined multiscale entropy: Application to 24-h holter recordings of heart period variability in healthy and aortic stenosis subjects. IEEE Transactions on Biomedical Engineering, 56(9), 2202–2213. 10.1109/TBME.2009.2021986 [DOI] [PubMed] [Google Scholar]
  • 10.Wu S. D., Wu C. W., Lin S. G., Wang C. C., & Lee K. Y. (2013). Time Series Analysis Using Composite Multiscale Entropy. Entropy, 15, 1069–1084. [Google Scholar]
  • 11.Wu S. D., Wu C. W., Lee K. Y., & Lin S. G. (2013). Modified multiscale entropy for short-term time series analysis. Physica A: Statistical Mechanics and its Applications, 392(23), 5865–5873. [Google Scholar]
  • 12.Humeau-Heurtier A., Baumert M., Mahé G., & Abraham P. (2014). Multiscale Compression Entropy of Microvascular Blood Flow Signals: Comparison of Results from Laser Speckle Contrast and Laser Doppler Flowmetry Data in Healthy Subjects. Entropy, 16(11), 5777–5795. [Google Scholar]
  • 13.Arif M., & Aziz W. (2005). Application of threshold based acceleration change index (TACI) in heart rate variability analysis. Physiological Measurement 26: 653–665. 10.1088/0967-3334/26/5/007 [DOI] [PubMed] [Google Scholar]
  • 14.Ashkenazy Y., Ivanov P. C., Havlin S., Peng C. K., Yamamoto Y., Goldberger A. L., et al. (2000). Decomposition of heartbeat time series: scaling analysis of the sign sequence. Computers in Cardiology 27: 139–142. [PubMed] [Google Scholar]
  • 15.Peng C. K., Havlin S., Stanley H. E., & Goldberger a L(1995b). Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos: 82–87. 10.1063/1.166141 [DOI] [PubMed] [Google Scholar]
  • 16.Garcia-Gonzalez M. A., Rames-Castro J., & Fernandez-Chimeno M. (2003). A new index for the analysis of heart rate variability dynamics: characterization and application. Physiological Measurement 24: 819–832. 10.1088/0967-3334/24/4/301 [DOI] [PubMed] [Google Scholar]
  • 17.Pan Y. H., Lin W. Y., Wang Y. H., & Lee K. T (2011). Computing multiscale entropy with orthogonal range search. J. Mar. Sci. Technol. 19, 107–113. [Google Scholar]
  • 18.Hussain L., Aziz W., Saeed S., Shah S. A., Nadeem M. S. A., Awan I. A., et al. (2018). Quantifying the dynamics of electroencephalographic (EEG) signals to distinguish alcoholic and non-alcoholic subjects using an MSE based KD tree algorithm. Biomedical Engineering/Biomedizinische Technik, 63(4), 481–490. [DOI] [PubMed] [Google Scholar]
  • 19.Abbas S. A., Riaz R., Kazmi S. Z. H., Rizvi S. S., & Kwon S. J. (2018). Cause Analysis of Caesarian Sections and Application of Machine Learning Methods for Classification of Birth Data. IEEE Access, 6, 67555–67561. [Google Scholar]
  • 20.Goldberger AL, Amaral LAN, Glass L, Hausdorff JM, Ivanov PCh, Mark RG, et al. (2000) Components of a New Research Resource for Complex Physiologic Signals. Circulation 101(23):e215–e220. 10.1161/01.cir.101.23.e215 [DOI] [PubMed] [Google Scholar]
  • 21.Shah S.A.A., Habib N., Nadeem M.S.A., Alshdadi A.A., Alqarni M. and Aziz W., (2020). Extraction of Dynamical Information and Classification of Heart Rate Variability Signals Using Scale Based Permutation Entropy Measures. TRAITEMENT DU SIGNAL, 37(3), pp.355–365. [Google Scholar]
  • 22.Awan I., Aziz W., Shah I.H., Habib N., Alowibdi J.S., Saeed S., et al. , 2018. Studying the dynamics of interbeat interval time series of healthy and congestive heart failure subjects using scale based symbolic entropy analysis. PloS one, 13(5), p.e0196823 10.1371/journal.pone.0196823 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Elena G Tolkacheva

20 Jul 2020

PONE-D-20-07743

MULTISCALE BASED NONLINEAR DYNAMICS ANALYSIS OF HEART RATE VARIABILITY SIGNALS

PLOS ONE

Dear Dr. Kwon,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please address all comments indicated by the Reviewers.

Please submit your revised manuscript by Sep 03 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

We look forward to receiving your revised manuscript.

Kind regards,

Elena G. Tolkacheva, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Thank you for inlcuding your competing interests statement; "The authors have declared that no competing interests exist."

We note that one or more of the authors are employed by a commercial company:

Raptor Interactive (Pty) Ltd

  1. Please provide an amended Funding Statement declaring this commercial affiliation, as well as a statement regarding the Role of Funders in your study. If the funding organization did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and/or research materials, please review your statements relating to the author contributions, and ensure you have specifically and accurately indicated the role(s) that these authors had in your study. You can update author roles in the Author Contributions section of the online submission form.

Please also include the following statement within your amended Funding Statement.

“The funder provided support in the form of salaries for authors [insert relevant initials], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ‘author contributions’ section.”

If your commercial affiliation did play a role in your study, please state and explain this role within your updated Funding Statement.

2. Please also provide an updated Competing Interests Statement declaring this commercial affiliation along with any other relevant declarations relating to employment, consultancy, patents, products in development, or marketed products, etc.  

Within your Competing Interests Statement, please confirm that this commercial affiliation does not alter your adherence to all PLOS ONE policies on sharing data and materials by including the following statement: "This does not alter our adherence to  PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests) . If this adherence statement is not accurate and  there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include both an updated Funding Statement and Competing Interests Statement in your cover letter. We will change the online submission form on your behalf

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Partly

Reviewer #3: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper discusses a multiscale based nonlinear dynamics analysis of heart rate variability signals. The presentation of the content is fine and the data is well explained. However, it is unclear what is new here compared with the existing methods. In addition, the significance of the results is lacked. Therefore, I suggest to decline this paper for publication.

Reviewer #2: The proposed method of using time evolution of heart rate variability captured by the so called Multi-scale based Acceleration Change Index for heart abnormality detection is very interesting. I have the following suggestions before the publication.

The abstract is too long. I would suggest to make the abstract concise and remove the . For instance, the importance of heart rhythm monitoring for early diagnosis of disease using ECG signals is a well-known fact and that part can be summarize.

I suggest you add a more comprehensive References. For instance there exist recent works on predictive analysis of ECG signals that solve similar problems.

Use consistent format for acronyms. For instance lowercase first letter is used for "differentiated time series (DNN)" while uppercase first letter is used for "Acceleration Change Index (ACI)".

Please clarify why the sign information (the slope of acceleration) is sufficient for some diagnosis cases, as it is known that there are many abnormalities like "supraventicular arrhythmia" that can be captured by analyzing the morphology of the ECG signal.

The results show a strong improvement for MACI vs ACI analysis in terms of the area under the ROC curve.

I would encourage you compare your method to some existing methods in addition to the internal comparison between the ACI and MCI approaches.

Reviewer #3: Based on an existing index Acceleration Change Index (ACI) for describing heart rate variability (HRV), this paper proposes to feed coarse-grained HRV data to ACI. The so-called multiscale ACI (MACI) seems to improve the performance of ACI in distinguishing between healthy and pathologic subjects. However, more validations are needed. Moreover, comparison to other methods is missing despite so many existing methods for this purpose.

Specific comments:

1. The proposed approach is called multiscale ACI. However, in the end, only one scale is used. The current approach is more like an ACI on coarse-grained time series with a tunable scale parameter. Can you use different scales at the same time to make this a real multiscale approach? A simple example would be just taking the average over a few $\\tau$ values. Of course, linear or non-linear models can be trained using multiple scales but this will involve more validation such as training-testing splits.

2. Is the coarse-graining procedure stable? In other words, if the averaging brackets are switched one step to the right (e.g., deleting x1 in the time series), will the new index change a lot? A more detailed quantitative justification for this would be helpful.

3. This is related to comment 1. In Fig. 2, how is the choice of whether to use more scale made? Are you merely iterating over a predefined set of $\\tau$ values? Or is there any criteria to decide whether to try more $\\tau$ values given the current computation results?

4. In the applications, there is an optimal $\\tau$ value of 3. It would be helpful to test whether this optimal value is consistent, e.g., by subsampling the datasets and see if 3 is still an optimal value.

5. The performance advantage of the coarse-grained approach is clear, but there is little interpretation presented. Can you use some example time series and visualize the difference among ACI, MACI with optimal $\\tau$, MACI with suboptimal $\\tau$ on the intermediate calculation results as described in the ACI algorithm.

6. Due to the small data size, I recommend using some statistical tests to further support the performance improvements observed in Fig. 4 and 7.

7. There are so many other indices for characterizing HRV, such as the ones listed in “Shaffer, Fred, and J. P. Ginsberg. "An overview of heart rate variability metrics and norms." Frontiers in public health 5 (2017): 258.” Comparison to the popular ones should be included. The paper that introduced ACI (Gonzalez et al 2003) did do some comparison to four other indices. But that comparison was on a different dataset and more methods have been proposed during the pase 17 years. Therefore, a fair comparison to other methods on the dataset used in this paper should be included.

8. This is related to comment 7. In the first paragraph of “Materials and Methods”, the authors claimed that “no other index except ACI provide significant difference between the groups”. In the original publication which this paper heavily based on, the authors compared ACI with four other indices and found that ACI is the best among the five. Thus, this statement in its current form is too strong and the context of Gonzalez et al (2003) should be included here.

9. There are many grammar errors in the manuscript. I strongly recommend the authors to carefully proofread the manuscript.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Dr. Abolfazl Razi

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Elena G Tolkacheva

23 Nov 2020

MULTISCALE BASED NONLINEAR DYNAMICS ANALYSIS OF HEART RATE VARIABILITY SIGNALS

PONE-D-20-07743R1

Dear Dr. Chung,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Elena G. Tolkacheva, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #3: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #3: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #3: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors made a substantial change, which makes the revision much more clear than the original submission. I think this version is ready for publication.

Reviewer #3: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #3: No

Acceptance letter

Elena G Tolkacheva

2 Dec 2020

PONE-D-20-07743R1

Multiscale based nonlinear dynamics analysis of heart rate variability signals

Dear Dr. Chung:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Elena G. Tolkacheva

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.pdf

    Data Availability Statement

    The data used in the study is publicly available at https://physionet.org/about/database/. We have used following specific datasets. • MIT-BIH Normal Sinus Rhythm Database. https://physionet.org/content/nsrdb/1.0.0/ • Normal Sinus Rhythm RR Interval Database. https://physionet.org/content/nsr2db/1.0.0/ • BIDMC Congestive Heart Failure Database. https://physionet.org/content/chfdb/1.0.0/ • Congestive Heart Failure RR Interval Database. https://physionet.org/content/chf2db/1.0.0/ • MIT-BIH Atrial Fibrillation Database. https://physionet.org/content/afdb/1.0.0/.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES